By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


Medical Device

Company News
Celsion Corporation (CLSN) Reports Second Quarter 2015 Financial Results And Provides Business Update 8/10/2015 9:41:59 AM
Celsion Corporation (CLSN) And myTomorrows Expand ThermoDox European Early Access Program To Include Patients With Primary Liver Cancer And Liver Cancer Metastases 8/10/2015 8:08:31 AM
Celsion Corporation (CLSN) Announces Updated Overall Survival Data From HEAT Study Of ThermoDox In Primary Liver Cancer 8/6/2015 6:50:12 AM
Celsion Corporation (CLSN) To Hold Second Quarter 2015 Financial Results Conference Call On Monday, August 10, 2015 8/3/2015 8:10:09 AM
Celsion Corporation (CLSN) Announces Continuing Positive Data From Its Phase 2 DIGNITY Study In Breast Cancer 7/6/2015 7:22:17 AM
Celsion Corporation (CLSN) To Present At Cantor Fitzgerald's Inaugural Healthcare Conference On July 8, 2015 7/1/2015 7:43:51 AM
ASCO15: Celsion Corporation (CLSN) Presents GEN-1 Immunotherapy Phase 1b Results In Recurrent Ovarian Cancer At ASCO 2015 6/1/2015 6:39:48 AM
Celsion Corporation (CLSN) Announces $8 Million At-The-Market Registered Direct Offering 5/28/2015 7:24:48 AM
Celsion Corporation (CLSN) Announces Potent, Durable Preclinical Lung Expression Data For Its Novel TheraSilence RNA Program 5/21/2015 6:45:28 AM
Celsion Corporation (CLSN) Announces Publication Of Preclinical Data Demonstrating Lung Specific Delivery of microRNA-145 Inhibitor Using Its Novel TheraSilence Platform 5/15/2015 6:18:02 AM